Lexeo Therapeutics (LXEO) PT Lowered to $9 at Leerink Partners
Tweet
Share
E-mailGet Alerts LXEO Hot Sheet
Price: $4.78 +1.70%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
Leerink Partners analyst Mani Foroohar lowered the price target on Lexeo Therapeutics (NASDAQ: LXEO) to $9.00 (from $10.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guggenheim Downgrades Alumis Inc (ALMS) to Neutral
- Virtus Convertible & Income Fund declares preferred share distribution
- DelphX closes C$52,500 private placement, updates on CRS platform
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
